期刊文献+

聚桂醇联合Nd:YAG激光治疗婴幼儿混合型血管瘤疗效评价 被引量:4

Analysis of the Therapeutic Effects of Lauromacrogol Combined with Nd:YAG Laser in the Treatment of Infantile Mixed Hemangioma
下载PDF
导出
摘要 目的:观察聚桂醇联合Nd:YAG激光治疗婴幼儿混合型血管瘤的疗效。方法:选取119例婴幼儿混合型血管瘤患者,采用聚桂醇联合Nd:YAG激光治疗,定期观察瘤体的大小、颜色、质地及并发症,随访6个月,根据治疗次数及瘤体缩小情况评价疗效。结果:采用聚桂醇联合Nd:YAG激光治疗婴幼儿混合型血管瘤,治疗2~8次,总有效率87.39%。治疗中发现,疗效与患儿年龄、瘤体的薄厚程度有关(P<0.05),瘤体越薄,治疗次数越少;瘤体越厚,治疗次数越多。皮损发病部位对疗效影响差异无统计学意义(P>0.05)。结论:聚桂醇联合Nd:YAG激光治疗婴幼儿混合型血管瘤安全、有效,不良反应少。 Objective To observe the effects of lauromacrogol combined with Nd:YAG laser in the treatment of infantile mixed hemangioma.Methods 119 cases of infantile mixed hemangiomas in our hospital were treated with lauromacrogol combined with Nd:YAG laser.The size,color,texture and complications of hemangioma were observed regularly.All patients were followed up for 6 months,and the curative effect was evaluated according to the number of treatments and the reduction of tumor size at the end of treatment.Results Using lauromacrogol combined with Nd:YAG laser therapy for infantile mixed hemangiomas,after 2~8 times of treatment,the total effective rate was 87.39%.The curative effect was related to the age of the children and the thickness of the tumor(P<0.05),the thinner the tumor,the fewer times of treatment,the thicker the tumor,the more times of treatment,there was no significant difference in the effect of lesion site on the curative effect(P>0.05).Conclusion The combination of lauromacrogol with Nd:YAG laser in the treatment of infantile mixed hemangioma is safe and effective,and low complication occurrence.
作者 钟欣 郑罡 丁敏 李晶冰 王一臣 张艺龄 ZHONG Xin;ZHENG Gang;DING Min;LI Jing-bing;WANG Yi-chen;ZHANG Yi-ling(Department of Dermatology,Xuzhou Central Hospital, Xuzhou 221006, Jiangsu, China)
出处 《中国美容医学》 CAS 2019年第1期55-57,共3页 Chinese Journal of Aesthetic Medicine
基金 徐州中心医院博士(硕士)创新团队科技项目(XZS201658)
关键词 婴幼儿 混合型血管瘤 聚桂醇 ND:YAG激光 infant mixed hemangioma lauromacrogol Nd:YAG laser
  • 相关文献

参考文献5

二级参考文献60

  • 1周国瑜,沈玲悦,田克斌,张志愿,梁军艳,朱玉兰,陈锦安.长脉冲可调脉宽Gentle YAG 1064nm激光治疗颌面部血管瘤113例效果评估[J].上海口腔医学,2006,15(3):250-253. 被引量:45
  • 2Haggstmm AN, Drolet BA, Baselga E, et al. Prospective study of infantile hemangiomas : demographic, prenatal, and perinatal characteristics [J]. J Pediatr, 2007,150(3) :291-294.
  • 3Haggstrom AN, Lammer E J, Schneider RA, et al. Patterns of infantile hemangiomas: new clues to hemangioma pathogenesis and embryonic facial development [J]. Pediatrics, 2006,117 (3) :698-703.
  • 4Amir J, Metzker A, Krikler R, et al. Strawberry hemangloma in preterm infants [ J ]. Pediatr Dermatol, 1986,3 (4) : 331-332.
  • 5Andersen IG, Rechnitzer C, Charabi B. Effectiveness of propanolol for treatment of infantile haemangioma [J]. Dan Med J, 2014, 61(2) : A4776.
  • 6Sethuraman G, Yenamandra VK, Gupta V. Management of infantile hemangiomas: current trends [J]. J Cutan Aesthet Surg, 2014,7(2) :75-85.
  • 7Cerrati EW, 0 TM, Chung H, et al. Diode laser for the treatment of telangiectasias following hemangioma involution [J]. Otolaryngo[ Head Neck Surg, 2015,152(2):239-243,.
  • 8de Graaf M, Raphael MF, Breugem CC, et al. Treatment of infantile haemangiomas with atenolol: comparison with a historical propranolol group [J]. J Plast Reconstr Aesthet Surg, 2013,66(12) : 1732-1740.
  • 9Blanchet C, Nicollas R, Bigorre M, et al. Management of infantile subglottic hemangioma: acebutolol or propranolol? [J]. Int J Pediatr Otorhinolaryngol, 2010,74 (8) : 959-961.
  • 10Ran Y, Chen S, Dai Y, et al. Successful treatment of oral itraconazole for infantile hemangiomas: a case series [J]. J Dermatol, 2015,42(2) :202-206.

共引文献66

同被引文献32

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部